Neglo David, Adzaho Francisca, Agbo Irene A, Arthur Richmond, Sedohia Daniel, Tettey Clement Okraku, Waikhom Sayanika Devi
Department of Basic Sciences, School of Basic and Biomedical Sciences, University of Health and Allied Sciences, PMB 31, Ho, Ghana.
Department of Biomedical Sciences, School of Basic and Biomedical Sciences, University of Health and Allied Sciences, PMB 31, Ho, Ghana.
Evid Based Complement Alternat Med. 2022 Mar 21;2022:9373524. doi: 10.1155/2022/9373524. eCollection 2022.
The rapid emergence and spread of antimicrobial resistance has become a global public health concern that threatens the effective treatment of infectious diseases. One major approach adopted to overcome antimicrobial resistance is the use of plant extracts individually and/or with combination of antibiotics with plant extracts, which may lead to new ways of treating infectious diseases and essentially representing a potential area for further future investigations. In this study, the antifungal activities of leaf and flower extracts against fluconazole-resistant strains (isolated from pregnant women with vulvovaginal candidiasis) and anti-methicillin-resistant (MRSA) were evaluated by agar well diffusion, microdilution, and biofilm inhibition assays. Subsequently, the determination of the combined antimicrobial activity of the individual plant extracts with (fluconazole and voriconazole) and (ampicillin, tetracycline, and streptomycin) against strains and MRSA, respectively, was evaluated by checkerboard microdilution assay. Results from the study showed that the antimicrobial activity of the two plant extracts determined by time-kill kinetics was fungistatic with their MICs ranging from 0.1 to 4 mg/mL. Interestingly, all extracts were proved as good biofilm inhibitors of resistant and MRSA from 10.1 to 98.82%. Their combination interaction with fluconazole, voriconazole, ampicillin, tetracycline, and streptomycin ranged from synergy to antagonism as per the parameters used. Overall, these results showed that leaf and flower extracts have significant antifungal property. Furthermore, leaf and flower extracts alone or in combination with fluconazole and voriconazole could provide a promising approach to the management of candidiasis caused by drug-resistant strains as well as their interaction with the antibacterial agents to combat the common infections caused by MRSA.
抗菌药物耐药性的迅速出现和传播已成为一个全球公共卫生问题,威胁着传染病的有效治疗。为克服抗菌药物耐药性而采用的一种主要方法是单独使用植物提取物和/或将抗生素与植物提取物联合使用,这可能会带来治疗传染病的新方法,并且本质上代表了一个未来值得进一步研究的潜在领域。在本研究中,通过琼脂孔扩散法、微量稀释法和生物膜抑制试验,评估了叶提取物和花提取物对耐氟康唑菌株(从患有外阴阴道念珠菌病的孕妇中分离)和耐甲氧西林金黄色葡萄球菌(MRSA)的抗真菌活性。随后,通过棋盘微量稀释试验评估了各植物提取物分别与(氟康唑和伏立康唑)以及(氨苄青霉素、四环素和链霉素)联合对上述菌株和MRSA的抗菌活性。研究结果表明,通过时间杀菌动力学测定的两种植物提取物的抗菌活性具有抑菌作用,其最低抑菌浓度(MIC)范围为0.1至4mg/mL。有趣的是,所有提取物都被证明是耐药菌株和MRSA的良好生物膜抑制剂,抑制率从10.1%到98.82%。根据所使用的参数,它们与氟康唑、伏立康唑、氨苄青霉素、四环素和链霉素的联合相互作用范围从协同到拮抗。总体而言,这些结果表明叶提取物和花提取物具有显著的抗真菌特性。此外,叶提取物和花提取物单独使用或与氟康唑和伏立康唑联合使用,可能为耐药菌株引起的念珠菌病的管理提供一种有前景的方法,以及它们与抗菌剂相互作用以对抗由MRSA引起的常见感染。